Table 4.
Adverse Events
| Mosapride CR (n = 54) | Nortriptyline (n = 50) | |
|---|---|---|
| Subjects of adverse events | 8 (14.8) | 6 (12.0) |
| Kind of adverse eventsa | ||
| Headache, dizziness, and sleepiness | 2 (3.7) | 3 (6.0) |
| Palpitation | 0 (0) | 1 (2.0) |
| Gastrointestinal dysfunction | 4 (7.4) | 3 (6.0) |
| Insomnia | 1 (1.8) | 2 (4.0) |
| Dysuria | 1 (1.8) | 0 (0) |
| Fatigue | 1 (1.8) | 0 (0) |
| Pruritus, sweat | 2 (3.7) | 0 (0) |
| Oropharyngeal pain, cough | 1 (1.8) | 1 (2.0) |
aThe types of adverse reactions included all of the subjects’ various adverse events.
CR, controlled-release.
Data are presented as n (%).